M A11 (Alendronate 35 mg)

Pill imprint M A11 has been identified as Alendronate sodium 35 mg.

Alendronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substance Act (CSA).

Alendronate sodium

Imprint:

M A11

Strength:

35 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Bisphosphonates

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-3568

Inactive Ingredients:

silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
sodium lauryl sulfate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.